daunorubicin has been researched along with polonium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akudugu, JM; Howell, RW; Neti, PV | 1 |
| Akudugu, JM; Howell, RW | 2 |
3 other study(ies) available for daunorubicin and polonium
| Article | Year |
|---|---|
Changes in lognormal shape parameter guide design of patient-specific radiochemotherapy cocktails.
Topics: Algorithms; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Citric Acid; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Drug Combinations; Drug Design; Polonium; Radiometry; Radiopharmaceuticals | 2011 |
Flow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line; Cell Survival; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Flow Cytometry; Monte Carlo Method; Polonium; Radiopharmaceuticals; Spectrometry, Fluorescence | 2012 |
A method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po.
Topics: Alpha Particles; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Cricetinae; Daunorubicin; Doxorubicin; Monte Carlo Method; Polonium; Radiopharmaceuticals; Reproducibility of Results | 2012 |